Mandate

Vinge advises Enea AB (publ) in connection with the sale of Enea’s Nordic consultancy operations

March 07, 2012

Vinge has advised Enea AB (publ) in connection with the sale of Enea’s Nordic consultancy operations, including the Swedish consultancy companies in Stockholm, Lund and Linköping to Xdin AB. Xdin AB is a subsidiary of the Alten Group, a leading global technology consultancy group with its headquarters in Paris. The sale is a part of Enea’s corporate strategy to focus on becoming a world leader in relation to operating system solutions for wireless communications. The companies sold have 226 employees and approximately 90 sub-consultants which comprises approximately half of Enea’s total  consultancy operations. The Nordic companies have an aggregate annual turnover of approximately SEK 300 million. The purchase price amounted to SEK 148.5 million. Closing took place on 16 February 2012. 

Vinge’s  team consisted of responsible partner Jesper Ottergren together with associates Anna Edström and Ida Christensson.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025